Company / Cash & Equivalents
Scienture Holdings, Inc. Cash & Equivalents History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$151.9K
FY2023
5-year range
$151.9K / $3.1M
FY2019-FY2023
Trend
-86.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 3 consecutive years, from $6M in FY2020 to $151,908 in FY2023.
Based on SEC 10-K filings.
$151,908 in FY2023 with a 3-year CAGR of -70.5%.
Declined from $3M to $151,908 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -70.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Scienture Holdings, Inc.'s cash & equivalents has declined for 3 consecutive years.
- 3-year CAGR of -70.5%, indicating a declining trend.
- In FY2023, cash & equivalents decreased 86.6% year-over-year.
- Peak cash & equivalents was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.01 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $151.9K | -86.6% |
| FY2022 | $1.1M | -63.7% |
| FY2021 | $3.1M | -47.2% |
| FY2020 | $5.9M | +106.1% |
| FY2019 | $2.9M | - |
| FY2018 | - | - |
| FY2016 | $78.7K | -88.8% |
| FY2015 | $705.6K | +736.8% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026